Raha Kaushik, Peters Martin B, Wang Bing, Yu Ning, Wollacott Andrew M, Westerhoff Lance M, Merz Kenneth M
Department of Chemistry, Quantum Theory Project, University of Florida, 2328 New Physics Building, P.O. Box 118435, Gainesville, FL 32611-8435, United States.
Drug Discov Today. 2007 Sep;12(17-18):725-31. doi: 10.1016/j.drudis.2007.07.006. Epub 2007 Aug 31.
Herein we will focus on the use of quantum mechanics (QM) in drug design (DD) to solve disparate problems from scoring protein-ligand poses to building QM QSAR models. Through the variational principle of QM we know that we can obtain a more accurate representation of molecular systems than classical models, and while this is not a matter of debate, it still has not been shown that the expense of QM approaches is offset by improved accuracy in DD applications. Objectively validating the improved applicability and performance of QM over classical-based models in DD will be the focus of research in the coming years along with research on the conformational sampling problem as it relates to protein-ligand complexes.
在此,我们将专注于量子力学(QM)在药物设计(DD)中的应用,以解决从蛋白质-配体构象评分到构建量子力学定量构效关系(QM QSAR)模型等不同问题。通过量子力学的变分原理,我们知道与经典模型相比,我们可以获得分子系统更精确的表示,虽然这一点并无争议,但在药物设计应用中,量子力学方法的成本是否能被提高的准确性所抵消,仍未得到证实。在未来几年,客观验证量子力学在药物设计中相较于基于经典模型的改进适用性和性能,将与研究与蛋白质-配体复合物相关的构象采样问题一起,成为研究的重点。